Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Cardiovascular Medical Device Market

ID: MRFR/MED/28667-HCR
128 Pages
Rahul Gotadki
Last Updated: May 21, 2026

Cardiovascular Medical Device Market Research Report: Size, Share, Trend Analysis By Device Type (Cardiac Implants, Diagnostic Imaging Equipment, Extracorporeal Life Support (ECLS), Surgical Tools and Equipment), By Indication (Coronary Artery Disease, Heart Failure, Arrhythmias, Valvular Heart Disease), By Technology (Bioresorbable Devices, Robotic-Assisted Surgery, Wearable Monitoring Systems, 3D Printing), By End Users (Hospitals, Ambulatory Surgical Centers, Cardiac Rehabilitation Facilities, Home Healthcare Settings), By Reimbursement Model (Fee-for-Service, Bundled Payments, Value-Based Purchasing, Subscription Models) and By Regional- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Cardiovascular Medical Device Market Infographic
Summary Table of Contents Segmentation Download PDF

Cardiovascular Medical Device Market Summary

According to MRFR analysis, the Cardiovascular Medical Device Market Size was valued at USD 50.72 Billion in 2024. The market is projected to grow from USD 52.72 Billion in 2025 to USD 77.52 Billion by 2035, registering a CAGR of 3.9% during the forecast 2025–2035. North America led the market with over 42.35% share, generating around USD 21.48 billion in revenue. 
 
The Cardiovascular Medical Device Market is expanding due to the rising prevalence of heart diseases, increasing aging populations, and growing demand for minimally invasive cardiac procedures. Key trends include advancements in implantable devices, transcatheter technologies, and digital monitoring systems that enhance early diagnosis, treatment precision, and long-term cardiovascular disease management.
 
WHO reports that about 19.8 million deaths in 2022 were attributed to cardiovascular diseases, representing roughly 32% of all global deaths.

Key Market Trends & Highlights

The Cardiovascular Medical Device Market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • North America leads Cardiovascular Medical Device Market, accounting for over 40.02% global revenue share in 2024.
  • Europe market reached USD 15.21 billion in 2024, capturing around 29.99% share with strong regulatory and healthcare infrastructure support.
  • Cardiovascular diseases cause 17.9 million deaths annually, significantly driving demand for advanced diagnostic and therapeutic cardiovascular medical devices globally.
  • Wearable monitoring systems hold over 55% share in 2024, driven by increasing demand for continuous and remote cardiac monitoring solutions.

Market Size & Forecast

2024 Market Size 50.72 (USD Billion)
2035 Market Size 77.52 (USD Billion)
CAGR (2025 - 2035) 3.93%

Major Players

Companies such as Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Edwards Lifesciences Corporation (US), Terumo Corporation (JP), Stryker Corporation (US), Cardinal Health (US) are some of the major participants in the Cardiovascular Medical Device Market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Cardiovascular Medical Device Market Trends

The Cardiovascular Medical Device Market is currently experiencing a dynamic evolution, driven by advancements in technology and an increasing prevalence of cardiovascular diseases. Innovations in device design and functionality are enhancing patient outcomes and improving the efficiency of healthcare delivery. The integration of digital health solutions, such as telemedicine and remote monitoring, is reshaping how cardiovascular conditions are managed, allowing for more personalized treatment plans.

Furthermore, regulatory bodies are adapting to these changes, streamlining approval processes for new devices, which may encourage further innovation and investment in this sector. In addition, the growing awareness of heart health among the global population is likely to propel demand for cardiovascular medical devices. As healthcare systems prioritize preventive care, there is a noticeable shift towards early detection and intervention strategies. This trend may lead to an increase in the adoption of diagnostic tools and minimally invasive procedures. Overall, the Cardiovascular Medical Device Market appears poised for substantial growth, with a focus on enhancing patient care and outcomes through innovative solutions.

Technological Advancements

The Cardiovascular Medical Device Market is witnessing rapid technological advancements that enhance device performance and patient safety. Innovations such as bioresorbable stents and advanced imaging techniques are becoming more prevalent, potentially leading to improved treatment outcomes. These developments may also facilitate the integration of artificial intelligence in diagnostics and monitoring, further transforming patient management.

  • According to the World Health Organization, cardiovascular diseases cause around 17.9 million deaths each year, making them the leading cause of death globally and highlighting the need for advanced diagnostic and therapeutic technologies.

Shift Towards Minimally Invasive Procedures

There is a discernible shift towards minimally invasive procedures within the Cardiovascular Medical Device Market. This trend is driven by the desire for reduced recovery times and lower complication rates. As surgical techniques evolve, devices designed for less invasive interventions are gaining traction, which could lead to broader acceptance among healthcare providers and patients alike.

  • Public health authorities such as the Pan American Health Organization and the European Centre for Disease Prevention and Control also highlight the growing use of advanced medical technologies and interventional procedures aimed at reducing complications and improving recovery times for cardiovascular patients.

Increased Focus on Preventive Care

The emphasis on preventive care is becoming more pronounced in the Cardiovascular Medical Device Market. Healthcare systems are increasingly prioritizing early detection and management of cardiovascular conditions. This focus may drive demand for diagnostic devices and wearable technologies that monitor heart health, potentially leading to better patient outcomes and reduced healthcare costs.

  • Organizations including UNICEF and the Global Fund to Fight AIDS, Tuberculosis and Malaria also support global health initiatives focused on strengthening screening, monitoring, and prevention programs, which contribute to increasing adoption of diagnostic and wearable cardiovascular monitoring technologies.

Cardiovascular Medical Device Market Drivers

Growing Awareness of Heart Health

The increasing awareness of heart health among the general population is driving the Cardiovascular Medical Device Market. Educational campaigns and initiatives aimed at promoting heart health have led to a more informed public, resulting in higher demand for preventive measures and medical interventions. As individuals become more conscious of risk factors associated with cardiovascular diseases, they are more likely to seek medical advice and treatment.
 
This shift in consumer behavior is reflected in the rising sales of cardiovascular devices, as patients actively pursue options for monitoring and improving their heart health. Furthermore, healthcare providers are responding to this trend by offering more comprehensive cardiovascular care solutions, thereby expanding the market. The emphasis on preventive care is expected to continue, further bolstering the demand for innovative medical devices.

Increasing Healthcare Expenditure

The rise in healthcare expenditure across various regions is a significant driver for the Cardiovascular Medical Device Market. Governments and private sectors are allocating more resources to healthcare, with spending on cardiovascular care witnessing notable increases. Reports indicate that healthcare spending is expected to reach trillions of dollars in the next few years, with a substantial portion directed towards cardiovascular health. This financial commitment facilitates the adoption of advanced medical technologies and devices, enhancing the quality of care provided to patients.
 
Additionally, as healthcare systems prioritize the management of chronic diseases, the demand for cardiovascular devices is likely to escalate. This trend not only supports the growth of the market but also encourages innovation, as companies strive to meet the evolving needs of healthcare providers and patients alike.

Regulatory Support for Medical Innovations

Regulatory bodies are increasingly supporting the development and approval of new cardiovascular medical devices, which serves as a crucial driver for the Cardiovascular Medical Device Market. Streamlined approval processes and initiatives aimed at fostering innovation are encouraging manufacturers to bring new technologies to market more rapidly. For instance, the introduction of expedited pathways for breakthrough devices has significantly reduced the time required for approval, allowing for quicker access to life-saving technologies.
 
This regulatory environment not only enhances competition among manufacturers but also stimulates investment in research and development. As a result, the market is likely to witness a surge in innovative products designed to address various cardiovascular conditions. The proactive stance of regulatory agencies is expected to contribute positively to the overall growth of the industry.

Rising Incidence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases is a primary driver for the Cardiovascular Medical Device Market. According to recent statistics, cardiovascular diseases account for a substantial portion of global mortality rates, with estimates suggesting that they are responsible for nearly 31% of all deaths. This alarming trend necessitates the development and deployment of advanced medical devices aimed at prevention, diagnosis, and treatment.
 
As healthcare systems strive to address this growing burden, investments in innovative cardiovascular technologies are likely to surge. The demand for devices such as stents, pacemakers, and implantable defibrillators is expected to rise, thereby propelling the market forward. Furthermore, the aging population, which is more susceptible to heart-related ailments, adds to the urgency for effective cardiovascular solutions, indicating a robust growth trajectory for the industry.

Technological Innovations in Medical Devices

Technological advancements play a pivotal role in shaping the Cardiovascular Medical Device Market. Innovations such as 3D printing, artificial intelligence, and telemedicine are revolutionizing the way cardiovascular conditions are diagnosed and treated. For instance, the integration of AI in imaging technologies enhances the accuracy of diagnostics, leading to timely interventions.
 
Moreover, the development of wearable devices that monitor heart health in real-time is gaining traction, appealing to both patients and healthcare providers. The market for these devices is projected to expand significantly, with estimates indicating a compound annual growth rate of over 10% in the coming years. As manufacturers continue to invest in research and development, the introduction of next-generation devices is anticipated, further driving market growth and improving patient outcomes.

Market Segment Insights

By Device Type: Cardiac Implants (Largest) vs. Diagnostic Imaging Equipment (Fastest-Growing)

The cardiovascular medical device market showcases a diverse range of device types, with cardiac implants holding the largest market share of 52%. These implants are crucial for managing various cardiovascular conditions, leading to substantial demand in both emerging and developed markets. Diagnostic imaging equipment, on the other hand, is rapidly capturing market interest, reflecting the growing emphasis on early detection and preventive healthcare, which is becoming an essential part of patient management.

Cardiac Implants (Dominant) vs. Extracorporeal Life Support (Emerging)

Cardiac implants are a dominant feature of the cardiovascular medical device market, benefiting from technological advancements and the increasing prevalence of heart diseases. They include devices such as pacemakers and stents, which play a vital role in patient recovery and quality of life. Conversely, extracorporeal life support (ECLS) systems represent an emerging technology in this space, gaining traction due to their critical role in cardiac surgeries and support during severe cardiac conditions. The growth of ECLS is driven by its effectiveness in providing temporary support, particularly in cases where traditional approaches are inadequate, thereby attracting attention from healthcare facilities seeking innovative solutions.

By Indication: Coronary Artery Disease (Largest) vs. Heart Failure (Fastest-Growing)

The cardiovascular medical device market is largely influenced by various indications. Coronary artery disease (CAD) remains the largest segment, significantly dominating market share with 46% due to the increasing prevalence of heart diseases globally. This is followed by heart failure, arrhythmias, and valvular heart disease, which collectively contribute to the overall market dynamics. The focus on early detection and intervention has spurred growth across all indications, with significant investments in research and development fostering innovative device solutions. The heart failure segment is projected as the fastest-growing area within the cardiovascular medical device market, fueled by an aging population and rising healthcare expenditures. Increasing awareness regarding the management of heart conditions and advancements in technology are driving demand. Additionally, the development of minimally invasive treatment options and wearable devices is contributing to the growth of arrhythmias and valvular heart disease, as healthcare providers seek efficient treatment alternatives for these conditions.

Coronary Artery Disease (Dominant) vs. Arrhythmias (Emerging)

Coronary artery disease (CAD) holds a dominant position in the cardiovascular medical device market, primarily due to its high prevalence and the critical need for timely intervention. Devices such as stents and angioplasty balloons play a key role in managing CAD, thus making it an essential focus for manufacturers and healthcare providers. On the other hand, arrhythmias represent an emerging market with rapid innovation occurring in diagnostic and treatment devices. The rise in prevalence of arrhythmias has prompted significant advancements in technologies, such as implantable devices and ablation therapies. As healthcare systems evolve, the integration of these emerging technologies into standard practice is expected to enhance patient outcomes and drive growth in this dynamic segment.

By Technology: Wearable Monitoring Systems (Largest) vs. Bioresorbable Devices (Fastest-Growing)

In the Cardiovascular Medical Device Market, the technology segment exhibits strong diversity, with Wearable Monitoring Systems holding the largest share of 55% due to their increasing adoption among patients for continuous health monitoring. Meanwhile, Bioresorbable Devices have emerged as a promising innovation, gaining traction for their advantages in minimizing long-term complications associated with permanent implants. The growth in these areas reflects a shift towards more patient-friendly and efficient treatment solutions.

Technology: Wearable Monitoring Systems (Dominant) vs. Bioresorbable Devices (Emerging)

Wearable Monitoring Systems are at the forefront of the Cardiovascular Medical Device Market, allowing for real-time health monitoring and data collection, greatly benefitting both patients and healthcare professionals. Their dominance is driven by advancements in technology, enabling continuous tracking of vital signs and early detection of potential health issues. Conversely, Bioresorbable Devices represent an emerging trend, particularly in interventional cardiology, as they reduce the need for additional surgical procedures by naturally dissolving after fulfilling their purpose. This innovation is fueled by growing concerns regarding implant longevity and patient safety, suggesting a strong future position for bioresorbable technologies.

By End User: Hospitals (Largest) vs. Home Healthcare Settings (Fastest-Growing)

Within the Cardiovascular Medical Device Market, hospitals hold the largest share of 64%, being the primary setting for advanced cardiac procedures and interventions. Their well-established infrastructure and availability of skilled healthcare professionals enable them to leverage cutting-edge cardiovascular technologies. Ambulatory surgical centers and cardiac rehabilitation facilities also contribute to the market, but to a lesser extent, focusing on specific cardiac procedures and rehabilitation programs. As healthcare systems evolve, these segments are gaining importance. Growth trends within the end user segment are influenced by several factors, including an aging population and an increased prevalence of cardiovascular diseases. Home healthcare settings are becoming the fastest-growing segment as advancements in telehealth and remote monitoring technologies enable more patients to manage their cardiovascular conditions at home. The shift towards outpatient care reflects a broader trend of patient preference for convenient, home-based care options.

Hospitals (Dominant) vs. Home Healthcare Settings (Emerging)

Hospitals represent the dominant end user in the Cardiovascular Medical Device Market, with a vast array of advanced medical devices utilized for diagnosis, treatment, and monitoring of cardiovascular conditions. Their ability to provide comprehensive care using the latest technologies positions them at the forefront of the market. In contrast, home healthcare settings are an emerging segment, gaining traction due to the increasing acceptance of home-based treatment. This shift is driven by technological advancements in remote monitoring and telemedicine, allowing chronic cardiovascular patients to receive care outside traditional hospital environments. Home healthcare promotes better patient compliance and comfort, making it an appealing alternative for many. As regulations evolve and technology continues to improve, the significance of both these segments will likely increase in the coming years.

By Reimbursement Model: Fee-for-Service (Largest) vs. Value-Based Purchasing (Fastest-Growing)

In the Cardiovascular Medical Device Market, the reimbursement model segment is dominated by Fee-for-Service, which continues to capture the largest market share of 61%. This traditional payment system pays healthcare providers for each service rendered, making it favored by many practitioners. On the other hand, Value-Based Purchasing is gaining traction among providers and payers alike as it emphasizes patient outcomes and efficiency, though it currently holds a smaller share compared to Fee-for-Service. As the market evolves, there is a notable shift towards bundled payments and value-based purchasing models. These trends are driven by increasing pressure to reduce healthcare costs while improving quality and outcomes. More healthcare stakeholders are now recognizing the long-term benefits of investing in value-based models, creating a competitive landscape where flexibility and patient-centered care are essential for growth.

Fee-for-Service (Dominant) vs. Value-Based Purchasing (Emerging)

Fee-for-Service remains the dominant reimbursement model in the Cardiovascular Medical Device Market, as it allows providers to receive a straightforward payment for each procedure or device used. This model, while widely accepted, has faced criticism for potentially incentivizing overutilization of services. In contrast, Value-Based Purchasing is an emerging approach that focuses on the actual outcomes of treatments rather than the volume of services delivered. With a growing emphasis on patient satisfaction and effective care, this model rewards healthcare providers for achieving better health results for patients, thus aligning financial incentives with quality care. As reimbursement strategies adapt, those adopting value-based methods are set to capitalize on the changing landscape.

Get more detailed insights about Cardiovascular Medical Device Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America leads in the Cardiovascular Medical Device Market Size, accounting for over 40.02% of the global revenue in 2024. Key growth drivers include an aging population, increasing prevalence of cardiovascular diseases, and advancements in technology. Regulatory support from agencies like the FDA has also catalyzed innovation and market entry for new devices, enhancing patient care and outcomes. 

The United States is the primary contributor, with major players like Medtronic, Abbott Laboratories, and Boston Scientific leading the market. The competitive landscape is characterized by continuous innovation and strategic partnerships among these companies. The presence of advanced healthcare infrastructure further supports the growth of cardiovascular medical devices in this region.

  • The Centers for Disease Control and Prevention (CDC) reports that heart disease remains the leading cause of death in the United States, accounting for approximately 695,000 deaths annually, or 1 in every 5 deaths. This significantly drives demand for advanced cardiovascular diagnostic and therapeutic devices.

Europe : Regulatory Framework Enhances Growth

Europe Cardiovascular Medical Device Market was valued at USD 15.21 billion in 2024, making it the second-largest regional market with a 30% share. The region benefits from a robust regulatory framework, including the Medical Device Regulation (MDR), which ensures high safety and efficacy standards. Increasing healthcare expenditure and a growing elderly population are significant demand drivers, alongside rising awareness of cardiovascular health. 

Leading countries in this market include Germany, France, and the UK, where companies like B. Braun Melsungen AG and Edwards Lifesciences Corporation are prominent. The competitive landscape is marked by innovation and collaboration among key players, focusing on developing advanced technologies to meet the evolving needs of patients and healthcare providers. The European market is poised for steady growth, driven by these factors.

  • The European Centre for Disease Prevention and Control (ECDC) indicates that cardiovascular diseases remain a leading health burden across Europe, contributing significantly to morbidity and mortality. Increasing adoption of preventive screening programs and advanced medical technologies is driving demand for innovative cardiovascular devices across healthcare systems.

Asia-Pacific : Emerging Market with High Potential

Asia-Pacific is an emerging powerhouse in the cardiovascular medical device market, holding approximately 20% of the global market share. The region is witnessing rapid growth due to increasing healthcare investments, rising awareness of cardiovascular diseases, and a growing middle-class population. Countries like China and India are leading this growth, supported by favorable government initiatives and investments in healthcare infrastructure. 

China is the largest market in the region, with significant contributions from local and international players like Terumo Corporation and Stryker Corporation. The competitive landscape is evolving, with a focus on innovation and affordability to cater to the diverse needs of the population. As healthcare access improves, the demand for advanced cardiovascular devices is expected to rise significantly in the coming years.

Middle East and Africa : Untapped Market with Opportunities

The Middle East and Africa represent a resource-rich frontier for the cardiovascular medical device market, holding about 10% of the global market share. The region is characterized by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Government initiatives aimed at improving healthcare infrastructure and access are key growth drivers, alongside a growing awareness of cardiovascular health among the population. Countries like South Africa and the UAE are leading the market, with a mix of local and international players. 

The competitive landscape is gradually evolving, with companies focusing on innovative solutions tailored to the unique needs of the region. As healthcare systems develop, the demand for cardiovascular medical devices is expected to grow, presenting significant opportunities for market players.

Cardiovascular Medical Device Market Regional Image

Key Players and Competitive Insights

The Cardiovascular Medical Device Market is currently characterized by a dynamic competitive landscape, driven by technological advancements, increasing prevalence of cardiovascular diseases, and a growing aging population. Major players such as Medtronic (US), Abbott Laboratories (US), and Boston Scientific (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) emphasizes innovation through continuous product development, particularly in minimally invasive procedures, while Abbott Laboratories (US) focuses on expanding its portfolio through strategic acquisitions and partnerships.
 
Boston Scientific (US) appears to be leveraging digital transformation initiatives to improve patient outcomes and operational efficiency, collectively shaping a competitive environment that prioritizes innovation and patient-centric solutions. The market structure is moderately fragmented, with a mix of established players and emerging companies vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of global economic fluctuations.
 
The collective influence of these key players fosters a competitive atmosphere where agility and responsiveness to market demands are paramount, allowing for a diverse range of products and services tailored to various regional needs. In August 2025, Medtronic (US) announced the launch of its next-generation transcatheter aortic valve replacement (TAVR) system, which is designed to enhance procedural efficiency and patient recovery times. This strategic move underscores Medtronic's commitment to innovation in cardiovascular interventions, potentially solidifying its leadership position in the TAVR market segment.
 
The introduction of this advanced technology may not only improve patient outcomes but also strengthen Medtronic's competitive edge against rivals. In July 2025, Abbott Laboratories (US) expanded its collaboration with a leading telehealth provider to integrate remote monitoring capabilities into its cardiovascular devices. This partnership is indicative of Abbott's strategic focus on digital health solutions, which could enhance patient engagement and adherence to treatment protocols. By leveraging telehealth technologies, Abbott is likely positioning itself to meet the growing demand for remote patient management, thereby enhancing its market presence in the cardiovascular sector.
 
In September 2025, Boston Scientific (US) unveiled a new suite of digital health tools aimed at improving the management of heart failure patients. This initiative reflects Boston Scientific's ongoing commitment to integrating digital solutions into its product offerings, which may facilitate better patient monitoring and outcomes. The strategic importance of this move lies in its potential to differentiate Boston Scientific in a competitive market increasingly focused on technology-driven healthcare solutions. As of October 2025, current competitive trends in the Cardiovascular Medical Device Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence.
 
Strategic alliances are becoming increasingly vital, as companies seek to enhance their technological capabilities and expand their market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains, suggesting a transformative shift in how companies approach market challenges and opportunities.

Key Companies in the Cardiovascular Medical Device Market include

Industry Developments

  • Q2 2024: Boston Scientific to acquire Silk Road Medical for $1.2 billion Boston Scientific announced a definitive agreement to acquire Silk Road Medical, a developer of devices for stroke prevention in patients with carotid artery disease, for $1.2 billion in cash. The deal expands Boston Scientific’s portfolio in the vascular intervention space.
  • Q2 2024: Medtronic wins FDA approval for Symplicity Spyral renal denervation system Medtronic received FDA approval for its Symplicity Spyral renal denervation system, a device designed to treat hypertension, marking a significant regulatory milestone for the company’s cardiovascular business.
  • Q1 2024: Abbott launches TriClip transcatheter tricuspid valve repair system in Europe Abbott announced the commercial launch of its TriClip transcatheter tricuspid valve repair system in select European markets following CE Mark approval, expanding its structural heart device offerings.
  • Q2 2024: Shockwave Medical completes acquisition of Neovasc Inc. Shockwave Medical finalized its acquisition of Neovasc Inc., a company specializing in devices for refractory angina, strengthening Shockwave’s position in the cardiovascular device sector.
  • Q1 2024: FDA approves Edwards Lifesciences’ EVOQUE tricuspid valve replacement system Edwards Lifesciences received FDA approval for its EVOQUE tricuspid valve replacement system, the first transcatheter therapy for tricuspid regurgitation to be approved in the United States.
  • Q2 2024: CardioSignal raises $15M Series B to expand AI-powered heart disease detection platform CardioSignal, a health tech startup focused on AI-driven heart disease detection, secured $15 million in Series B funding to accelerate product development and expand its global reach.
  • Q1 2024: Biotronik announces partnership with Mayo Clinic for remote cardiac monitoring Biotronik entered into a strategic partnership with Mayo Clinic to advance remote cardiac monitoring solutions, aiming to improve patient outcomes through enhanced data analytics and device connectivity.
  • Q2 2024: Philips launches new Azurion image-guided therapy platform for cardiovascular procedures Philips introduced its latest Azurion platform, designed to support complex cardiovascular interventions with advanced imaging and workflow capabilities, targeting hospitals and specialty clinics.
  • Q1 2024: Terumo opens new manufacturing facility for cardiovascular devices in North Carolina Terumo announced the opening of a new manufacturing facility in North Carolina dedicated to producing advanced cardiovascular devices, supporting increased demand and expanding its U.S. footprint.
  • Q2 2024: Shockwave Medical completes $200M public offering Shockwave Medical completed a $200 million public offering to fund further development and commercialization of its intravascular lithotripsy technology for cardiovascular applications.
  • Q1 2024: Boston Scientific announces partnership with HeartFlow to advance coronary artery disease diagnostics Boston Scientific formed a partnership with HeartFlow to integrate HeartFlow’s AI-powered coronary artery disease diagnostic platform with Boston Scientific’s interventional cardiology solutions.
  • Q2 2024: Abbott appoints new head of global cardiovascular device division Abbott named Dr. Lisa Chen as the new head of its global cardiovascular device division, signaling a strategic focus on innovation and international expansion.

Future Outlook

Cardiovascular Medical Device Market Future Outlook

The Cardiovascular Medical Device Market size is projected to reach USD 77.52 Billion by 2035, growing at a CAGR of 3.9%.

New opportunities lie in:

  • Development of AI-driven diagnostic tools for early detection. Expansion of telehealth services for remote patient monitoring. Investment in biodegradable stents to enhance patient safety.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Cardiovascular Medical Device Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Rehabilitation Facilities
  • Home Healthcare Settings

Cardiovascular Medical Device Market Indication Outlook

  • Coronary Artery Disease
  • Heart Failure
  • Arrhythmias
  • Valvular Heart Disease

Cardiovascular Medical Device Market Technology Outlook

  • Bioresorbable Devices
  • Robotic-Assisted Surgery
  • Wearable Monitoring Systems
  • 3D Printing

Cardiovascular Medical Device Market Device Type Outlook

  • Cardiac Implants
  • Diagnostic Imaging Equipment
  • Extracorporeal Life Support (ECLS)
  • Surgical Tools and Equipment

Cardiovascular Medical Device Market Reimbursement Model Outlook

  • Fee-for-Service
  • Bundled Payments
  • Value-Based Purchasing
  • Subscription Models

Report Scope

MARKET SIZE 2024 50.72(USD Billion)
MARKET SIZE 2025 52.72(USD Billion)
MARKET SIZE 2035 77.52(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.93% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Edwards Lifesciences Corporation (US), Terumo Corporation (JP), Stryker Corporation (US), Cardinal Health (US)
Segments Covered Device Type, Indication, Technology, End Users, Reimbursement Model, Regional- Forecast to 2035
Key Market Opportunities Integration of artificial intelligence in cardiovascular diagnostics enhances patient outcomes and operational efficiency.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the cardiovascular medical device market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Cardiovascular Medical Device Market?

The market valuation was 50.72 USD Billion in 2024.

What is the projected market size for the Cardiovascular Medical Device Market by 2035?

The market is projected to reach 77.52 USD Billion by 2035.

What is the expected CAGR for the Cardiovascular Medical Device Market from 2025 to 2035?

The expected CAGR during the forecast period is 3.93%.

Which segments are included in the Cardiovascular Medical Device Market?

Key segments include Device Type, Indication, Technology, End User, and Reimbursement Model.

What are the projected revenues for Cardiac Implants by 2035?

Cardiac Implants are projected to generate revenues between 23.0 and 30.0 USD Billion by 2035.

How much is the market for Wearable Monitoring Systems expected to grow by 2035?

The market for Wearable Monitoring Systems is expected to grow to between 15.21 and 25.0 USD Billion by 2035.

What are the leading companies in the Cardiovascular Medical Device Market?

Key players include Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson.

What is the anticipated revenue for hospitals as an end user by 2035?

Hospitals are expected to generate revenues between 20.0 and 30.0 USD Billion by 2035.

What is the projected revenue for 3D Printing technology in the market by 2035?

3D Printing technology is projected to reach revenues between 20.3 and 29.52 USD Billion by 2035.

What reimbursement models are expected to be significant in the Cardiovascular Medical Device Market?

Significant reimbursement models include Fee-for-Service, Bundled Payments, and Value-Based Purchasing.

Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓